Helsinn and Riemser Extend Relationship in Germany

27 September 2011

Helsinn Group is reinforcing its cancer supportive care pipeline

27 September 2011

Helsinn Group and Eisai Inc. to start Phase III for prevention of CINV

26 September 2011

Helsinn Therapeutics Initiates Global Pivotal Phase III Clinical Program to Evaluate Anamorelin in Non-Small Cell Lung Cancer-Associated Anorexia/Cachexia

20 September 2011

Cerbios confirmed by D&B in the top 500 Swiss companies with Risk Indicator 1

6 September 2011

Cerbios founder and former president, received an honorary doctorate from St. Petersburg’s Society of Oncologists

18 May 2011

Helsinn Group Invests in Thorne Research

12 May 2011

mondoBIOTECH holding AG (SIX:RARE): Presenting at BIO-Europe Spring 2011 on March 16, 2011

14 March 2011